DrugPatentWatch Database Preview
CADUET Drug Profile
» See Plans and Pricing
When do Caduet patents expire, and when can generic versions of Caduet launch?
Caduet is a drug marketed by Pharmacia and is included in one NDA.
The generic ingredient in CADUET is amlodipine besylate; atorvastatin calcium. There are fifty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the amlodipine besylate; atorvastatin calcium profile page.
Summary for CADUET
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 109 |
| Clinical Trials: | 13 |
| Patent Applications: | 3,475 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CADUET |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CADUET |
| DailyMed Link: | CADUET at DailyMed |
Paragraph IV (Patent) Challenges for CADUET
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| CADUET | TABLET;ORAL | amlodipine besylate; atorvastatin calcium | 021540 | 2009-09-17 |
| CADUET | TABLET;ORAL | amlodipine besylate; atorvastatin calcium | 021540 | 2009-04-07 |
| CADUET | TABLET;ORAL | amlodipine besylate; atorvastatin calcium | 021540 | 2006-12-29 |
US Patents and Regulatory Information for CADUET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-009 | Jul 29, 2004 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-004 | Jan 30, 2004 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-001 | Jan 30, 2004 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CADUET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-011 | Jul 29, 2004 | Start Trial | Start Trial |
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-002 | Jan 30, 2004 | Start Trial | Start Trial |
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-010 | Jul 29, 2004 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CADUET
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Estonia | 9800015 | Start Trial |
| Japan | H0757751 | Start Trial |
| Japan | 4790194 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for CADUET
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1003503 | SZ 30/2006 | Austria | Start Trial | PRODUCT NAME: AMLODIPIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SÄUREADDITIONSALZ DESSELBEN IN KOMBINATION MIT ATORVASTATIN ODER EINEM PHARMAZEUTISCH ANNEHMBAREN SALZ DESSELBEN |
| 1915993 | 92315 | Luxembourg | Start Trial | PRODUCT NAME: COMBINAISON COMPRENANT ALISKIREN,OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE,ET AMLODIPINE,OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE |
| 1915993 | C300625 | Netherlands | Start Trial | PRODUCT NAME: COMBINATIE BEVATTENDE ALISKIREN, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE, OF EEN FARMACEUATISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110414 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
